Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.38%100.42M | 3.43%98.64M | 1.56%105.11M | -9.15%387.02M | -0.79%91.96M | -5.86%96.2M | -16.39%95.37M | -11.60%103.49M | -10.72%426.03M | -21.08%92.7M |
| Operating revenue | 4.38%100.42M | 3.43%98.64M | 1.56%105.11M | -9.15%387.02M | -0.79%91.96M | -5.86%96.2M | -16.39%95.37M | -11.60%103.49M | -10.72%426.03M | -21.08%92.7M |
| Cost of revenue | 4.74%83.94M | -5.10%82.47M | -3.01%86.63M | -9.41%333.03M | -12.46%76.67M | -9.37%80.14M | -9.92%86.9M | -6.12%89.32M | -18.85%367.62M | -5.52%87.57M |
| Gross profit | 2.58%16.48M | 91.03%16.17M | 30.42%18.48M | -7.56%54M | 198.65%15.3M | 16.69%16.06M | -51.88%8.46M | -35.39%14.17M | 142.05%58.41M | -79.32%5.12M |
| Operating expense | 12.85%16.73M | -24.34%10.98M | 2.08%15.55M | -34.79%59.95M | -62.99%15.38M | -0.65%14.82M | -20.08%14.51M | -11.97%15.24M | 56.33%91.93M | 147.32%41.55M |
| Selling and administrative expenses | -5.75%12.89M | 11.41%14.39M | 0.13%14.72M | -11.18%54.59M | -6.60%13.3M | -0.73%13.68M | -24.55%12.91M | -9.98%14.7M | 12.35%61.46M | -12.54%14.23M |
| -Selling and marketing expense | 56.57%2.28M | 67.42%2.45M | 74.97%3.29M | -27.56%6.31M | -31.50%1.52M | -26.24%1.45M | -44.43%1.46M | -1.00%1.88M | 5.96%8.71M | 17.34%2.21M |
| -General and administrative expense | -13.16%10.62M | 4.26%11.94M | -10.86%11.43M | -8.47%48.28M | -2.01%11.78M | 3.52%12.23M | -20.94%11.45M | -11.16%12.82M | 13.48%52.75M | -16.46%12.02M |
| Research and development costs | 0.53%952K | -1.46%742K | -8.25%756K | 2.66%3.21M | -1.01%683K | 24.93%947K | -1.18%753K | -9.85%824K | -7.85%3.12M | -5.09%690K |
| Other operating expenses | 1,363.96%2.88M | -592.99%-4.15M | 126.21%76K | -92.14%2.15M | -94.74%1.4M | -48.43%197K | 202.88%842K | -575.41%-290K | 3,730.53%27.35M | 13,348.26%26.63M |
| Operating profit | -120.24%-251K | 185.89%5.19M | 376.08%2.93M | 82.25%-5.95M | 99.77%-83K | 207.36%1.24M | -965.96%-6.04M | -122.93%-1.06M | 3.32%-33.52M | -557.33%-36.43M |
| Net non-operating interest income (expenses) | 35.09%-2.45M | 9.00%-2.68M | 4.88%-2.77M | -15.24%-13.16M | -2.93%-3.54M | -42.85%-3.77M | -12.63%-2.94M | -6.60%-2.91M | -87.58%-11.42M | -48.28%-3.44M |
| Non-operating interest expense | -35.09%2.45M | -9.00%2.68M | -4.88%2.77M | 8.02%11.38M | -31.14%1.76M | 42.85%3.77M | 12.63%2.94M | 6.60%2.91M | 104.54%10.53M | 84.73%2.55M |
| Total other finance cost | ---- | ---- | ---- | 100.67%1.79M | ---- | ---- | ---- | ---- | -5.32%890K | ---- |
| Other net income (expenses) | -93.54%400K | 1,663.25%6.19M | ||||||||
| Gain on sale of security | ---- | ---- | ---- | -47.68%304K | ---- | ---- | ---- | ---- | 85.03%581K | ---- |
| Special income (charges) | ---- | ---- | ---- | -98.29%96K | ---- | ---- | ---- | ---- | 15,056.76%5.61M | ---- |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | 98.29%-96K | ---- | ---- | ---- | ---- | -15,056.76%-5.61M | ---- |
| Income before tax | -6.69%-2.7M | 127.96%2.51M | 104.16%165K | 51.72%-18.71M | 90.42%-3.23M | 33.36%-2.53M | -182.61%-8.99M | -308.78%-3.97M | 4.10%-38.76M | -661.88%-33.69M |
| Income tax | -72.61%206K | -57.31%248K | -40.06%573K | -43.95%1.68M | -126.88%-611K | -10.58%752K | 202.47%581K | 113.87%956K | 135.14%2.99M | 137.87%2.27M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 11.50%-2.9M | 123.67%2.27M | 91.72%-408K | 51.16%-20.39M | 92.72%-2.62M | 29.23%-3.28M | -266.17%-9.57M | -438.63%-4.93M | -30.91%-41.75M | -399.72%-35.96M |
| Net income continuous operations | 11.50%-2.9M | 123.67%2.27M | 91.72%-408K | 51.16%-20.39M | 92.72%-2.62M | 29.23%-3.28M | -266.17%-9.57M | -438.63%-4.93M | -30.91%-41.75M | -399.72%-35.96M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 11.50%-2.9M | 123.67%2.27M | 91.72%-408K | 51.16%-20.39M | 92.72%-2.62M | 29.23%-3.28M | -266.17%-9.57M | -438.63%-4.93M | -30.91%-41.75M | -399.72%-35.96M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 11.50%-2.9M | 123.67%2.27M | 91.72%-408K | 51.16%-20.39M | 92.72%-2.62M | 29.23%-3.28M | -266.17%-9.57M | -438.63%-4.93M | -30.91%-41.75M | -399.72%-35.96M |
| Diluted earnings per share | 8.33%-0.11 | 122.86%0.08 | 88.89%-0.02 | 51.30%-0.75 | 93.23%-0.09 | 29.41%-0.12 | -250.00%-0.35 | -460.00%-0.18 | -30.51%-1.54 | -402.27%-1.33 |
| Basic earnings per share | 8.33%-0.11 | 122.86%0.08 | 88.89%-0.02 | 51.30%-0.75 | 93.23%-0.09 | 29.41%-0.12 | -250.00%-0.35 | -460.00%-0.18 | -30.51%-1.54 | -402.27%-1.33 |
| Dividend per share | -2.92%0.0251 | 0.10%0.0256 | -52.79%0.0245 | -53.70%0.1277 | -53.78%0.0244 | -64.79%0.0259 | -66.14%0.0256 | -29.93%0.0518 | -9.45%0.2757 | -28.39%0.0528 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.